Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography
The use of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for response assessment in lymphoma is now widespread. Prognostic information obtained from PET performed after two to three cycles of chemotherapy may guide more individualized, risk-adapted therapeutic strategies. Progress in...
Gardado en:
| Autor Principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley
2011-01-01
|
| Series: | Advances in Hematology |
| Acceso en liña: | http://dx.doi.org/10.1155/2011/271595 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|